Mitchell N. Cayen
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
Papers in
- Pharmacology 21
- Pharmacogenetics and Drug Metabolism 15
- Antibiotics Pharmacokinetics and Efficacy 14
- Drug-Induced Hepatotoxicity and Protection 5
-
- Peroxisome Proliferator-Activated Receptors 5
- Co-authors
- D. Dvornik (20 shared papers)Melton B. Affrime (13 shared papers)Eckhardt S. Ferdinandi (9 shared papers)E. Greselin (10 shared papers)Robert P. Clement (5 shared papers)Mark L. J. Reimer (1 shared paper)Mallé Jurima‐Romet (1 shared paper)J. Fred Pritchard (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Biochemical Pharmacology (5 papers)Drug Metabolism and Disposition (4 papers)Atherosclerosis (4 papers)The Journal of Clinical Pharmacology (3 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Mitchell N. Cayen
77 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 126
- Pharmacology 327
- Immunology and Allergy 82
- Pharmacology 216
- Biochemistry 67
- Clinical Biochemistry 54
Countries citing papers authored by Mitchell N. Cayen
This map shows the geographic impact of Mitchell N. Cayen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell N. Cayen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell N. Cayen more than expected).
Fields of papers citing papers by Mitchell N. Cayen
This network shows the impact of papers produced by Mitchell N. Cayen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell N. Cayen. The network helps show where Mitchell N. Cayen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell N. Cayen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 176 | |
| 2 | 2002 | 133 | |
| 3 | 1979 | 109 | |
| 4 | 1996 | 89 | |
| 5 | 2000 | 79 | |
| 6 | 1991 | 62 | |
| 7 | 2000 | 61 | |
| 8 | 1995 | 60 | |
| 9 | 1971 | 49 | |
| 10 | 1981 | 49 | |
| 11 | 1977 | 44 | |
| 12 | 2000 | 42 | |
| 13 | 1985 | 41 | |
| 14 | 1979 | 39 | |
| 15 | 1998 | 33 | |
| 16 | 1992 | 25 | |
| 17 | 1969 | 25 | |
| 18 | 2002 | 24 | |
| 19 | 2002 | 21 | |
| 20 | 1980 | 21 |
About Mitchell N. Cayen
Mitchell N. Cayen is a scholar working on Pharmacology, Molecular Biology, Pharmacology, Surgery and Oncology, having authored 77 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Cholesterol and Lipid Metabolism (11 papers), Drug Transport and Resistance Mechanisms (11 papers), Metabolism and Genetic Disorders (6 papers), Antibiotic Resistance in Bacteria (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). The work is most often cited by research in Pharmacology (327 citations), Immunology and Allergy (82 citations), Pharmacology (216 citations), Biochemistry (67 citations) and Clinical Biochemistry (54 citations). Mitchell N. Cayen has collaborated with scholars based in China, Canada and United States. Frequent co-authors include D. Dvornik, Melton B. Affrime, Eckhardt S. Ferdinandi, E. Greselin, Robert P. Clement, Mark L. J. Reimer, Mallé Jurima‐Romet, J. Fred Pritchard, Teddy Kosoglou and Kevin B. Alton. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Biochemical Pharmacology, Drug Metabolism and Disposition, Atherosclerosis and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.